RFI7206562024: Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Mozambique USAID-Maputo notices from 2024.
Mozambique USAID-Maputo offered grants of up to $40.0 million (at least $40.0 million) to any type of organization. Applications closed on June 14, 2024.
From the official notice on Grants.gov, last changed May 30, 2024. Checked November 7, 2026.
- Award ceiling$40.0 million
- Award floor$40.0 million
- Cost sharingNot required
- Funding typeOther
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| 72065624RFA00005 | August 1, 2024 | Closed September 30, 2024 | Closed |
Key dates
| Posted | May 7, 2024 |
|---|---|
| Deadline | June 14, 2024 |
| Archived by Grants.gov | June 29, 2024 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $40.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
This is a Request for Information (“RFI”) issued by the U.S. Agency for International Development (USAID) Mozambique for conducting market research in response to the questions provided in Attachment C. This RFI is issued solely for planning and information seeking purposes in accordance with FAR Part 10 and ADS 300. USAID will not pay for information submitted nor will it reimburse costs incurred by individuals or entities that elect to respond to this RFI. USAID/Mozambique intends to design a new Activity - Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA) - that will support and contribute to the Government of the Republic of Mozambique (GRM) to reach and sustain HIV epidemic control in three provinces - Sofala, Manica and Tete. This is anticipated to be a five (5) year award November - 2024 - 2029, with a total value of up to $40 million. The purpose of this communication is to obtain industry comment and input on the above-mentioned activity. More specifically, the RFI intends to: ● Assess the interest of potential organizations in submitting applications/proposals for the new USAID/ ESPERANÇA Activity. ● Gain technical and organizational insights in the capacity of potential organizations. ● Explore innovative approaches to partnering with organizations working in the same area; and ● Collect inputs to contribute to the improvement of the proposed Program Description (PD)/Scope of Work (SOW). Attachment C presents the set of questions to which organizations should respond. Note that this is a RFI and not a Request for Applications (RFA) or a Request for Proposal (RFP). This RFI is not to be construed as a commitment by the U.S. Government to issue any solicitation or ultimately an award based on this RFI, or to pay for any information submitted as a result of this request. It should be noted that responding to this RFI will not give any advantage to any organization in the subsequent procurement.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is RFI7206562024 still open?
No. It closed on June 14, 2024.
Who can apply for Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA)?
Mozambique USAID-Maputo accepted applications from any type of organization.
What is the deadline for Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA)?
Closed June 14, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $40.0 million each.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)